NFKB1 and malignant colon neoplasm: ARlncRNA CASC2 was detected to be lowly expressed in colon cancer cells and inhibited cell viability by down-regulating miR19a and inhibiting the NF-κB/p65, suggesting that CASC2 may be a prospective factor for the therapeutic therapy of colon cancer.58